Phase 2 Alopecia Areata Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- Men aged 25 to 59 years who have a common pattern of hair loss (male-pattern baldness) that falls within a certain range of severity, and who are being seen at the Dermatology Outpatient Clinic of Prof. Dr. I.G.N.G. Ngoerah General Hospital.
- Women aged 25 to 59 years who have a common pattern of hair loss (female-pattern hair loss) that falls within a certain range of severity, and who are being seen at the same clinic.
- Women who are not currently pregnant or breastfeeding.
- Patients who stopped taking anti-androgen medication or minoxidil (a common hair loss treatment) at least 1 month before the procedure.
- Patients who have no known allergies to the biological treatment substances used in this trial or to any materials used to prepare platelet-rich plasma (a treatment made from your own blood).
- Patients who can speak and read Indonesian and are willing to sign a consent form agreeing to take part.
Who may not be able to join:
- People who cannot speak or understand Indonesian, or who are not willing to sign a written consent form.
- People whose hair loss is caused by something other than common pattern baldness.
- Patients who are currently taking a type of medication called 5-alpha reductase inhibitors (used to treat hair loss or other conditions).
- Patients who have had steroid injections into their scalp within the last 6 months.
- Patients who currently have an active infection or active skin inflammation on the scalp.
- Patients with a known allergy to the biological treatment substances or materials used to prepare the platelet-rich plasma treatment.
- People with a history of raised/thickened scar tissue (hypertrophic scarring) or blood clotting disorders.
- Patients who are unlikely to be able to complete all parts of the study.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Terminal-to-Vellus Hair Ratio; Hair density
Can't join this trial?
Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.